Posted 3 weeks ago

Study of Amivantamab, a Human Bispecific EGFR and cMet Antibody, in Participants With Advanced Non-Small Cell Lung Cancer (CHRYSALIS)

ClinicalTrials.gov ID NCT02609776

Protocol ID JNJ-61186372COR3002

Sponsor Janssen Pharmaceutical